Compare Abbott India with ALEMBIC LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs ALEMBIC LTD - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA ALEMBIC LTD ABBOTT INDIA/
ALEMBIC LTD
 
P/E (TTM) x 44.7 73.7 60.7% View Chart
P/BV x 12.8 2.6 489.1% View Chart
Dividend Yield % 0.5 0.4 138.4%  

Financials

 ABBOTT INDIA   ALEMBIC LTD
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-18
ALEMBIC LTD
Mar-18
ABBOTT INDIA/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs6,11072 8,486.1%   
Low Rs3,99634 11,787.6%   
Sales per share (Unadj.) Rs1,552.24.7 33,022.1%  
Earnings per share (Unadj.) Rs188.86.1 3,093.3%  
Cash flow per share (Unadj.) Rs196.46.2 3,145.2%  
Dividends per share (Unadj.) Rs55.000.20 27,500.0%  
Dividend yield (eoy) %1.10.4 288.2%  
Book value per share (Unadj.) Rs796.640.7 1,959.1%  
Shares outstanding (eoy) m21.25267.03 8.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.311.3 28.9%   
Avg P/E ratio x26.88.7 308.5%  
P/CF ratio (eoy) x25.78.5 303.4%  
Price / Book Value ratio x6.31.3 487.1%  
Dividend payout %29.13.3 889.0%   
Avg Mkt Cap Rs m107,37614,139 759.4%   
No. of employees `0003.3NA-   
Total wages/salary Rs m3,937207 1,898.2%   
Avg. sales/employee Rs Th9,929.3NM-  
Avg. wages/employee Rs Th1,185.1NM-  
Avg. net profit/employee Rs Th1,207.7NM-  
INCOME DATA
Net Sales Rs m32,9851,255 2,627.9%  
Other income Rs m1,170370 316.0%   
Total revenues Rs m34,1551,625 2,101.3%   
Gross profit Rs m5,245111 4,721.0%  
Depreciation Rs m16238 428.3%   
Interest Rs m382 2,247.1%   
Profit before tax Rs m6,215442 1,406.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m01,212 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,20324 9,197.1%   
Profit after tax Rs m4,0121,630 246.2%  
Gross profit margin %15.98.9 179.7%  
Effective tax rate %35.45.4 653.8%   
Net profit margin %12.2129.8 9.4%  
BALANCE SHEET DATA
Current assets Rs m22,6551,867 1,213.4%   
Current liabilities Rs m6,681591 1,130.0%   
Net working cap to sales %48.4101.6 47.6%  
Current ratio x3.43.2 107.4%  
Inventory Days Days6594 68.7%  
Debtors Days Days2974 39.6%  
Net fixed assets Rs m8351,791 46.7%   
Share capital Rs m213534 39.8%   
"Free" reserves Rs m16,71510,324 161.9%   
Net worth Rs m16,92810,858 155.9%   
Long term debt Rs m041 0.0%   
Total assets Rs m24,16211,591 208.5%  
Interest coverage x163.7260.9 62.7%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.40.1 1,260.6%   
Return on assets %16.814.1 119.1%  
Return on equity %23.715.0 157.9%  
Return on capital %36.915.2 243.2%  
Exports to sales %01.5 0.0%   
Imports to sales %021.0 0.0%   
Exports (fob) Rs mNA19 0.0%   
Imports (cif) Rs mNA263 0.0%   
Fx inflow Rs m36919 1,899.7%   
Fx outflow Rs m3,807264 1,442.9%   
Net fx Rs m-3,438-244 1,406.6%   
CASH FLOW
From Operations Rs m1,527236 647.6%  
From Investments Rs m-2,148-224 959.1%  
From Financial Activity Rs m-1,024-27 3,850.8%  
Net Cashflow Rs m-1,646-15 11,118.9%  

Share Holding

Indian Promoters % 0.0 64.0 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 0.2 3,950.0%  
FIIs % 0.1 9.7 1.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 26.1 65.5%  
Shareholders   18,270 54,701 33.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   FULFORD INDIA  AUROBINDO PHARMA  IPCA LABS  WOCKHARDT  VENUS REMEDIES  

Compare ABBOTT INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Sep 20, 2019 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS